Dr. Pestell is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
233 South 10th Street
BLSB 1050
Philadelphia, PA 19107Phone+1 215-503-5692Fax+1 215-503-9334
Education & Training
- University of Western Australia Faculty of MedicineClass of 1982
Certifications & Licensure
- FL State Medical License 2019 - 2025
- PA State Medical License 2006 - 2022
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 2000
Publications & Presentations
PubMed
- 109 citationsRecent advances of highly selective CDK4/6 inhibitors in breast cancerHanxiao Xu, Shengnan Yu, Qian Liu, Xun Yuan, Sridhar Mani
Journal of Hematology & Oncology. 2017-04-24 - 69 citationsBiological functions of CDK5 and potential CDK5 targeted clinical treatmentsAlison B. Shupp, Mathew C. Casimiro, Richard G. Pestell
Oncotarget. 2017-01-06 - 305 citationsp300 and p300/cAMP-response element-binding protein-associated factor acetylate the androgen receptor at sites governing hormone-dependent transactivation.Maofu Fu, Chenguang Wang, Anne T. Reutens, Jian Wang, Ruth Hogue Angeletti
The Journal of Biological Chemistry. 2000-07-07
Press Mentions
- Former Jefferson Cancer Center Director Raises $2M for New 'Theranostics' StartupNovember 23rd, 2022
- CytoDyn Announces That Director Nominations by Rosenbaum/Patterson Activist Group Are InvalidAugust 2nd, 2021
- Effects of Differential Distributed-JUP on the Malignancy of Gastric CancerJuly 6th, 2020
- Join now to see all
Grant Support
- Impact Of Cyclin D1 Isoforms In Breast CancerNational Cancer Institute2010–2012
- Androgen Receptor Function In Prostate CancerNational Cancer Institute2009–2012
- Dach1/Eya Cell-Fate Determination Factor And Mammary TumoregenesisNational Cancer Institute2009–2011
- Senior LeadershipNational Cancer Institute2008–2011
- Radiation Research And TherapeuticsNational Cancer Institute2008–2011
- Proteomics And Molecular CharacterizationNational Cancer Institute2008–2011
- Developmental FundsNational Cancer Institute2008–2011
- Initiation And Maintenance In Mammary TumorigenesisNational Cancer Institute2006–2011
- Translational Research In CancerNational Cancer Institute2005–2011
- X-RAY ChrystallographyNational Cancer Institute2008–2010
- Translational ResearchNational Cancer Institute2008–2010
- Transgenic Knockout MiceNational Cancer Institute2008–2010
- Small Animal ImagingNational Cancer Institute2008–2010
- Protocol Specific Research Support (PSRS)National Cancer Institute2008–2010
- Protocol Review And Monitoring System (PRMS)National Cancer Institute2008–2010
- Program Planning And EvaluationNational Cancer Institute2008–2010
- LAB AnimalNational Cancer Institute2008–2010
- InformaticsNational Cancer Institute2008–2010
- Flow CytometryNational Cancer Institute2008–2010
- Data Safety Monitoring Board (DSMB)National Cancer Institute2008–2010
- Clinical Research Management OfficeNational Cancer Institute2008–2010
- Cancer GenomicsNational Cancer Institute2008–2010
- Cancer Center AdministrationNational Cancer Institute2008–2010
- BiostatisticsNational Cancer Institute2008–2010
- BioimagingNational Cancer Institute2008–2010
- Regulation Of Cyclin D1 ExpressionNational Cancer Institute2006–2010
- Molecular Biology And GeneticsNational Cancer Institute2008–2009
- Immunological Mechanisms In CancerNational Cancer Institute2008–2009
- Gastro Intestinal CancerNational Cancer Institute2008–2009
- Endocrine Mechanisms And Hormone Action In CancerNational Cancer Institute2008–2009
- Cell Biology And SignalingNational Cancer Institute2008–2009
- Cyclin D1 Regulation Of Nuclear Receptor Function In Breast CancerNational Cancer Institute2007–2008
- Automated High Throughput DNA SequencerNational Center For Research Resources2007
- Caveolin-1 And Cyclin D1 In Mammary TumorigenesisNational Cancer Institute2006
- Cyclin D1 Regulation Of Nuclear Receptor Function In Breast CA.National Cancer Institute2005–2006
- Cyclin D1 Regulation Of Nuclear Receptor Function In Breast CA.National Cancer Institute2005
- Cyclin D1 Function In Prostate CancerNational Cancer Institute2005
- Regulation Of Cyclin D1 ExpressionNational Cancer Institute2003–2005
- Initiation And Maintenance In Mammary TumorigenesisNational Cancer Institute2003–2005
- Cyclin D1 Function In Prostate CancerNational Cancer Institute2003–2005
- Caveolin-1 And Cyclin D1 In Mammary TumorigenesisNational Cancer Institute2003–2005
- Cancer Center Support GrantNational Cancer Institute2001–2005
- Cyclin D1 Regulation Of Nuclear Receptor FunctionNational Cancer Institute2004
- Initiation And Maintenance In Mammary TumorigenesisNational Cancer Institute2002
- Caveolin-1 And Cyclin D1 In Mammary TumorigenesisNational Cancer Institute2002
- Cyclin D1 Function In Prostate CancerNational Cancer Institute2001–2002
- Regulation Of Cyclin D1 ExpressionNational Cancer Institute2000–2002
- Breast Inducible Antisense Cyclin D1 Transgenic MiceNational Cancer Institute1998–2001
- Regulation Of Cyclin D1 ExpressionNational Cancer Institute1996–2000
- Extramural Research Facilities Construction ProjectsNational Center For Research Resources1999
- Breast Inducible Antisense Cyclin D1 Transgenic MiceNational Cancer Institute1997
- Transcriptional Regulation Of The CG Genes In CancerNational Cancer Institute1996–1997
- Regulation Of Cyclin D1 ExpressionNational Cancer Institute1996
- Transcriptional Regulation Of The CG Genes In CancerNational Cancer Institute1994–1995
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: